IBDEI16C ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20997,0)
 ;;=197.1^^118^1260^15
 ;;^UTILITY(U,$J,358.3,20997,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20997,1,1,0)
 ;;=1^197.1
 ;;^UTILITY(U,$J,358.3,20997,1,8,0)
 ;;=8^Secondary Malig Neo Mediastinum
 ;;^UTILITY(U,$J,358.3,20997,2)
 ;;=^267323
 ;;^UTILITY(U,$J,358.3,20998,0)
 ;;=197.2^^118^1260^16
 ;;^UTILITY(U,$J,358.3,20998,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20998,1,1,0)
 ;;=1^197.2
 ;;^UTILITY(U,$J,358.3,20998,1,8,0)
 ;;=8^Secondary Malig Neo Pleura
 ;;^UTILITY(U,$J,358.3,20998,2)
 ;;=^267324
 ;;^UTILITY(U,$J,358.3,20999,0)
 ;;=197.3^^118^1260^17
 ;;^UTILITY(U,$J,358.3,20999,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20999,1,1,0)
 ;;=1^197.3
 ;;^UTILITY(U,$J,358.3,20999,1,8,0)
 ;;=8^Secondary Malig Neo Resp Organs NEC
 ;;^UTILITY(U,$J,358.3,20999,2)
 ;;=^267325
 ;;^UTILITY(U,$J,358.3,21000,0)
 ;;=V65.3^^118^1261^4
 ;;^UTILITY(U,$J,358.3,21000,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21000,1,1,0)
 ;;=1^V65.3
 ;;^UTILITY(U,$J,358.3,21000,1,8,0)
 ;;=8^Dietary Surveil/Counseling
 ;;^UTILITY(U,$J,358.3,21000,2)
 ;;=^295563
 ;;^UTILITY(U,$J,358.3,21001,0)
 ;;=V79.1^^118^1261^1
 ;;^UTILITY(U,$J,358.3,21001,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21001,1,1,0)
 ;;=1^V79.1
 ;;^UTILITY(U,$J,358.3,21001,1,8,0)
 ;;=8^Alcoholism Screening
 ;;^UTILITY(U,$J,358.3,21001,2)
 ;;=^295678
 ;;^UTILITY(U,$J,358.3,21002,0)
 ;;=V79.0^^118^1261^3
 ;;^UTILITY(U,$J,358.3,21002,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21002,1,1,0)
 ;;=1^V79.0
 ;;^UTILITY(U,$J,358.3,21002,1,8,0)
 ;;=8^Depression Screening
 ;;^UTILITY(U,$J,358.3,21002,2)
 ;;=^295677
 ;;^UTILITY(U,$J,358.3,21003,0)
 ;;=V65.49^^118^1261^8
 ;;^UTILITY(U,$J,358.3,21003,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21003,1,1,0)
 ;;=1^V65.49
 ;;^UTILITY(U,$J,358.3,21003,1,8,0)
 ;;=8^Medication Counseling
 ;;^UTILITY(U,$J,358.3,21003,2)
 ;;=^303471
 ;;^UTILITY(U,$J,358.3,21004,0)
 ;;=V66.2^^118^1261^2
 ;;^UTILITY(U,$J,358.3,21004,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21004,1,1,0)
 ;;=1^V66.2
 ;;^UTILITY(U,$J,358.3,21004,1,8,0)
 ;;=8^Chemotherapy Convalescen
 ;;^UTILITY(U,$J,358.3,21004,2)
 ;;=^295568
 ;;^UTILITY(U,$J,358.3,21005,0)
 ;;=V76.10^^118^1261^11
 ;;^UTILITY(U,$J,358.3,21005,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21005,1,1,0)
 ;;=1^V76.10
 ;;^UTILITY(U,$J,358.3,21005,1,8,0)
 ;;=8^Screen Mal Neopl, Breast,Unsp
 ;;^UTILITY(U,$J,358.3,21005,2)
 ;;=^317968
 ;;^UTILITY(U,$J,358.3,21006,0)
 ;;=V76.2^^118^1261^9
 ;;^UTILITY(U,$J,358.3,21006,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21006,1,1,0)
 ;;=1^V76.2
 ;;^UTILITY(U,$J,358.3,21006,1,8,0)
 ;;=8^Screen Mal Neop-Cervix
 ;;^UTILITY(U,$J,358.3,21006,2)
 ;;=^295653
 ;;^UTILITY(U,$J,358.3,21007,0)
 ;;=V76.41^^118^1261^10
 ;;^UTILITY(U,$J,358.3,21007,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21007,1,1,0)
 ;;=1^V76.41
 ;;^UTILITY(U,$J,358.3,21007,1,8,0)
 ;;=8^Screen Mal Neop-Rectum
 ;;^UTILITY(U,$J,358.3,21007,2)
 ;;=^295655
 ;;^UTILITY(U,$J,358.3,21008,0)
 ;;=V26.33^^118^1261^7
 ;;^UTILITY(U,$J,358.3,21008,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21008,1,1,0)
 ;;=1^V26.33
 ;;^UTILITY(U,$J,358.3,21008,1,8,0)
 ;;=8^Genetic Counseling
 ;;^UTILITY(U,$J,358.3,21008,2)
 ;;=^332865
 ;;^UTILITY(U,$J,358.3,21009,0)
 ;;=V58.11^^118^1261^6
 ;;^UTILITY(U,$J,358.3,21009,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21009,1,1,0)
 ;;=1^V58.11
 ;;^UTILITY(U,$J,358.3,21009,1,8,0)
 ;;=8^Encounter for Chemotherapy
 ;;^UTILITY(U,$J,358.3,21009,2)
 ;;=^332869
 ;;^UTILITY(U,$J,358.3,21010,0)
 ;;=V58.12^^118^1261^5
 ;;^UTILITY(U,$J,358.3,21010,1,0)
 ;;=^358.31IA^8^2
